Generate Biomedicines, Inc. (GENB)
13.12
+0.03
(+0.23%)
USD |
NASDAQ |
May 29, 16:00
13.13
+0.01
(+0.08%)
After-Hours: 20:00
Generate Biomedicines Profit Margin (Quarterly) : -854.3% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -639.5% |
| Beam Therapeutics, Inc. | -297.2% |
| Arrowhead Pharmaceuticals, Inc. | -186.6% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
Profit Margin (Quarterly) Related Metrics
| Gross Profit Margin (Quarterly) | 54.69% |
| Operating Margin (Quarterly) | -887.5% |